Journal international du développement et de la recherche sur les médicaments

  • ISSN: 0975-9344
  • Indice h du journal: 44
  • Note de citation du journal: 59.93
  • Facteur d’impact du journal: 48.80
Indexé dans
  • Genamics JournalSeek
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • CiteFactor
  • Scimago
  • Répertoire d'indexation des revues de recherche (DRJI)
  • OCLC - WorldCat
  • Publions
  • MIAR
  • Commission des bourses universitaires
  • Pub européen
  • Google Scholar
  • Laboratoires secrets des moteurs de recherche
  • ResearchGate
Partager cette page


Collaboration and Partnerships in Drug Discovery: Advancing Healthcare Together

Sumeet Singh*

Collaboration and partnerships have become increasingly important in drug discovery as the complexity of diseases and the costs associated with drug development continue to rise. This abstract will discuss the role of collaboration and partnerships in advancing healthcare through drug discovery. The paper will explore different types of collaborations, such as public-private partnerships, academic-industry partnerships, and inter-industry partnerships, and highlight their advantages and challenges. The benefits of collaboration in drug discovery, including access to complementary expertise, resources, and technology, will be discussed. Additionally, the importance of open innovation, precompetitive collaborations, and data sharing in accelerating drug discovery and reducing costs will be emphasized. Finally, the paper will examine successful collaborations and partnerships in drug discovery, providing case studies to illustrate how effective collaborations can lead to new treatments and therapies that improve patient outcomes. Overall, the paper will show how collaboration and partnerships are critical to advancing healthcare and drug discovery and highlight the need for continued collaboration in the field.


Healthcare; Drug resistance; Collaboration; Research and development; Pharmaceutical industry; Drug discovery